Vascular endothelial microparticles-incorporated microRNAs are altered in patients with diabetes mellitus

[1]  A. Mebazaa,et al.  Circulating microRNAs and Outcome in Patients with Acute Heart Failure , 2015, PloS one.

[2]  R. Jove,et al.  MicroRNA-26a regulates insulin sensitivity and metabolism of glucose and lipids. , 2015, The Journal of clinical investigation.

[3]  Chaoqian Xu,et al.  MicroRNA-26a prevents endothelial cell apoptosis by directly targeting TRPC6 in the setting of atherosclerosis , 2015, Scientific Reports.

[4]  D. Lan,et al.  Diabetes and hyperlipidemia induce dysfunction of VSMCs: contribution of the metabolic inflammation/miRNA pathway. , 2015, American journal of physiology. Endocrinology and metabolism.

[5]  G. Nickenig,et al.  Abstract 9738: Endothelial Microparticles Reduce Icam-1 Expression in a Microrna-222-Dependent Mechanism , 2014 .

[6]  G. Nickenig,et al.  MicroRNA Expression in Circulating Microvesicles Predicts Cardiovascular Events in Patients With Coronary Artery Disease , 2014, Journal of the American Heart Association.

[7]  W. Timens,et al.  Prostaglandin E2 promotes MYCN non-amplified neuroblastoma cell survival via β-catenin stabilization , 2014, Journal of cellular and molecular medicine.

[8]  Michael J.A. Williams,et al.  Rapid onset of cardiomyopathy in STZ-induced female diabetic mice involves the downregulation of pro-survival Pim-1 , 2014, Cardiovascular Diabetology.

[9]  P. Manning,et al.  Cardiovascular microRNAs: as modulators and diagnostic biomarkers of diabetic heart disease , 2014, Cardiovascular Diabetology.

[10]  A. Tedgui,et al.  Microvesicles as Cell–Cell Messengers in Cardiovascular Diseases , 2014, Circulation research.

[11]  J. Bernheim,et al.  Vitamin D manipulates miR-181c, miR-20b and miR-15a in human umbilical vein endothelial cells exposed to a diabetic-like environment , 2014, Cardiovascular Diabetology.

[12]  G. Nickenig,et al.  Abstract 10882: Endothelial Microparticle-mediated Transfer of MicroRNA-126 Promotes Vascular Endothelial Cell Repair Via SPRED1 and is Abrogated in Glucose-damaged Endothelial Microparticles , 2013 .

[13]  R. Liao,et al.  MicroRNA-26a Regulates Pathological and Physiological Angiogenesis by Targeting BMP/SMAD1 Signaling , 2013, Circulation research.

[14]  Maarten Hulsmans,et al.  MicroRNA-containing microvesicles regulating inflammation in association with atherosclerotic disease. , 2013, Cardiovascular research.

[15]  Nikos Werner,et al.  High glucose condition increases NADPH oxidase activity in endothelial microparticles that promote vascular inflammation. , 2013, Cardiovascular research.

[16]  K. Vickers,et al.  Intercellular transport of microRNAs. , 2013, Arteriosclerosis, thrombosis, and vascular biology.

[17]  T. Lüscher,et al.  AngiomiR-126 expression and secretion from circulating CD34(+) and CD14(+) PBMCs: role for proangiogenic effects and alterations in type 2 diabetics. , 2013, Blood.

[18]  M. Rudin,et al.  Loss of AngiomiR-126 and 130a in Angiogenic Early Outgrowth Cells From Patients With Chronic Heart Failure: Role for Impaired In Vivo Neovascularization and Cardiac Repair Capacity , 2012, Circulation.

[19]  E. Latz,et al.  Endothelial Microparticle Uptake in Target Cells Is Annexin I/Phosphatidylserine Receptor Dependent and Prevents Apoptosis , 2012, Arteriosclerosis, thrombosis, and vascular biology.

[20]  M. Mayr,et al.  Prospective study on circulating MicroRNAs and risk of myocardial infarction. , 2012, Journal of the American College of Cardiology.

[21]  T. Chavakis,et al.  Developmental Endothelial Locus-1 (Del-1) Mediates Clearance of Platelet Microparticles by the Endothelium , 2012, Circulation.

[22]  M. Mayr,et al.  Atheroprotective communication between endothelial cells and smooth muscle cells through miRNAs , 2012, Nature Cell Biology.

[23]  A. Tijsen,et al.  Circulating microRNAs: novel biomarkers and extracellular communicators in cardiovascular disease? , 2012, Circulation research.

[24]  Manuel Mayr,et al.  MicroRNAs in vascular and metabolic disease. , 2012, Circulation research.

[25]  Mark Ziemann,et al.  Microparticles: major transport vehicles for distinct microRNAs in circulation , 2012, Cardiovascular research.

[26]  S. Fichtlscherer,et al.  Circulating microRNAs: biomarkers or mediators of cardiovascular diseases? , 2011, Arteriosclerosis, thrombosis, and vascular biology.

[27]  K. Vickers,et al.  MicroRNAs are Transported in Plasma and Delivered to Recipient Cells by High-Density Lipoproteins , 2011, Nature Cell Biology.

[28]  M. Mayr,et al.  Plasma MicroRNA Profiling Reveals Loss of Endothelial MiR-126 and Other MicroRNAs in Type 2 Diabetes , 2010, Circulation research.

[29]  Stefanie Dimmeler,et al.  Circulating MicroRNAs in Patients With Coronary Artery Disease , 2010, Circulation research.

[30]  Jessica A. Weber,et al.  Export of microRNAs and microRNA-protective protein by mammalian cells , 2010, Nucleic acids research.

[31]  E. Olson,et al.  MicroRNAs add a new dimension to cardiovascular disease. , 2010, Circulation.

[32]  Yue Li,et al.  Circulating microRNA: a novel potential biomarker for early diagnosis of acute myocardial infarction in humans. , 2010, European heart journal.

[33]  M. Hristov,et al.  Delivery of MicroRNA-126 by Apoptotic Bodies Induces CXCL12-Dependent Vascular Protection , 2009, Science Signaling.

[34]  Daniel B. Martin,et al.  Circulating microRNAs as stable blood-based markers for cancer detection , 2008, Proceedings of the National Academy of Sciences.

[35]  A. Tedgui,et al.  Microparticles and type 2 diabetes. , 2008, Diabetes & metabolism.

[36]  G. Sesti,et al.  Insulin-Dependent Activation of Endothelial Nitric Oxide Synthase Is Impaired by O-Linked Glycosylation Modification of Signaling Proteins in Human Coronary Endothelial Cells , 2002, Circulation.

[37]  H. Nonogi,et al.  Assessment of plasma miRNAs in congestive heart failure. , 2011, Circulation journal : official journal of the Japanese Circulation Society.